Trading Signals: EW Stock Price Prediction and Forecast (Thu. Jun. 5, 2008 - Wed. Sep. 27, 2023)(Edwards Lifesciences Corporation)
| EW latest price $70.8700 (-17.88%) ($69.7000 - $74.0000) on Fri. Oct. 28, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3% (three month average) | RSI | 34 | Latest Price | $70.8700(-17.88%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EW declines -3.3% a day on average for past five trading days. | Weekly Trend | EW declines -0.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EW advance at 0% a week (0% probability) ONLN(40%) IWF(39%) IWO(38%) HYG(37%) IBUY(37%) | Factors Impacting EW price | EW will decline at least -1.5% in a week (0% probabilities). UUP(-13%) VXX(-12%) TBT(-8%) XLP(-5%) UNG(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.5% (StdDev 3%) | Hourly BBV | -1.5 () | Intraday Trend | -2.7% | | | |
|
Resistance Level | $84.22 | 5 Day Moving Average | $82.91(-14.52%) | 10 Day Moving Average | $83.94(-15.57%) | 20 Day Moving Average | $84.22(-15.85%) | To recent high | -33.9% | To recent low | 0% | Market Cap | $44.039b | | | | Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into three areas: Transcatheter Heart Valves, Surgical Structural Heart and Critical Care. The Transcatheter Heart Valves portfolio includes technologies designed to treat heart valve disease using catheter-based approaches as opposed to open surgical techniques. Its portfolio includes technologies designed for nonsurgical replacement of heart valves. The Surgical Structural Heart portfolio includes tissue heart valves and heart valve repair products for the surgical replacement or repair of a patient's heart valve. The portfolio also includes a diverse line of cardiac surgery systems used during minimally invasive surgical procedures, and cannulae, embolic protection devices and other products used during cardiopulmonary bypass. The Critical Care portfolio products hemodynamic monitoring systems used to measure a patient's heart function and fluid status in surgical and intensive care settings. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.. |